Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Humana Inc (NYSE: HUM) closed the day trading at $261.61 down -3.46% from the previous closing price of $271.0. In other words, the price has decreased by -$3.46 from its previous closing price. On the day, 2.75 million shares were traded. HUM stock price reached its highest trading level at $268.0 during the session, while it also had its lowest trading level at $257.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Sell rating and assigned the stock a target price of $235.
On September 22, 2025, Evercore ISI started tracking the stock assigning a In-line rating and target price of $295.
Raymond James Upgraded its Mkt Perform to Outperform on May 01, 2025, while the target price for the stock was maintained at $315.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 32593661952 and an Enterprise Value of 22738311168. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.08, and their Forward P/E ratio for the next fiscal year is 19.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 0.185 whereas that against EBITDA is 5.663.
Stock Price History:
The Beta on a monthly basis for HUM is 0.41, which has changed by 0.02363348 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $315.35, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is -6.23%, while the 200-Day Moving Average is calculated to be 0.02%.
Shares Statistics:
Over the past 3-months, HUM traded about 1.96M shares per day on average, while over the past 10 days, HUM traded about 2567100 shares per day. A total of 120.27M shares are outstanding, with a floating share count of 119.99M. Insiders hold about 0.23% of the company’s shares, while institutions hold 95.49% stake in the company. Shares short for HUM as of 1759190400 were 3299575 with a Short Ratio of 1.69, compared to 1756425600 on 4625645. Therefore, it implies a Short% of Shares Outstanding of 3299575 and a Short% of Float of 3.08.
Dividends & Splits
HUM’s forward annual dividend rate is 3.54, up from 3.54 a year ago. Against a Trailing Annual Dividend Yield of 0.01306273. The stock’s 5-year Average Dividend Yield is 0.84. . The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-09-26. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The company has 24.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$3.71, with high estimates of -$2.97 and low estimates of -$4.14.
Analysts are recommending an EPS of between $17.26 and $16.57 for the fiscal current year, implying an average EPS of $17.04. EPS for the following year is $13.46, with 26.0 analysts recommending between $15.85 and $10.42.
Revenue Estimates
19 analysts predict $32B in revenue for . The current quarter. It ranges from a high estimate of $32.21B to a low estimate of $31.4B. As of . The current estimate, Humana Inc’s year-ago sales were $29.4BFor the next quarter, 19 analysts are estimating revenue of $31.85B. There is a high estimate of $32.38B for the next quarter, whereas the lowest estimate is $31.07B.
A total of 21 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.03B, while the lowest revenue estimate was $126.97B, resulting in an average revenue estimate of $128.28B. In the same quarter a year ago, actual revenue was $117.76BBased on 21 analysts’ estimates, the company’s revenue will be $135.08B in the next fiscal year. The high estimate is $145.97B and the low estimate is $121.6B.
